The principal business address of the Ascendant Reporting Persons is 11777 San Vincente Blvd., Suite 650, Los Angeles, California 90049. The principal business address of the Oaktree Reporting Persons, other than BAM and Partners, is c/o Oaktree Capital Management, L.P., 333 S. Grand Avenue, 28th Floor, Los Angeles, California 90071. The principal business address of BAM is 181 Bay Street, Suite 300, Toronto, Ontario, Canada, M5J 2T3 and the principal business address of Partners is 51 Yonge Street, Suite 400, Toronto, Ontario, Canada, M5E 1J1.
(d) and (e) During the last five years, none of the Reporting Persons and, to the best of their knowledge, none of the Covered Persons (i) has been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) or (ii) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. | Source and Amount of Funds or Other Consideration |
On July 24, 2020, ACP acquired 200,000 shares of the Issuer’s newly designated 12% Series B Cumulative Redeemable Preferred Stock, liquidation preference $1,000.00 per share (the “Series B Preferred Stock”), and the Warrants (collectively with the Series B Preferred Stock, the “Issuer’s Securities”), for an aggregate purchase price of $200,000,000, in accordance with the Securities Purchase Agreement, dated as of July 21, 2020, by and among the Issuer, ACP, the Operating Partnership, and, solely with respect to the guaranty therein, certain other parties thereto (the “Purchase Agreement”). The source of funds for such transaction was capital contributions of the members of ACP. ACP did not borrow funds to purchase the Issuer’s Securities.
Item 5(c) below is hereby incorporated by reference into this Item 3.
Item 4. | Purpose of Transaction |
The acquisitions of the Issuer securities made by the Reporting Persons described in this Schedule 13D were for investment purposes.
On July 21, 2020, the Issuer, the Operating Partnership, ACP and, solely with respect to the guaranty therein, certain other parties thereto entered into the Purchase Agreement. Pursuant to the Purchase Agreement, the Issuer, in a private placement made in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended, agreed to issue and sell to ACP 200,000 shares of Series B Preferred Stock and the Warrants to purchase 16,778,446 OP Units, for an aggregate purchase price of $200,000,000 (the “Private Placement”). ACP has also committed to provide, upon satisfaction of certain conditions, up to an additional $250 million to purchase additional shares of the Series B Preferred Stock, during the 18 months following the consummation of the Private Placement, to be used for specified purposes as agreed by the Issuer and ACP. The Private Placement closed on July 24, 2020.
Purchase Agreement
Director Designation and Election Rights
The Issuer has agreed to cause two designees of ACP to be appointed as members of the Board of Directors of the Issuer (the “Board”) (the “Purchaser Directors”) at the closing of the Private Placement, which will initially be Mr. Gimelstob and Alex Halpern (“Mr. Halpern”). As set forth in the Articles Supplementary (as defined below), such Purchaser Directors will serve until the next annual meeting of stockholders of the Issuer and, thereafter, holders of at least majority of the liquidation preference of the Series B Preferred Stock then outstanding (the “Majority Holders”) will be entitled to elect (i) two Purchaser Directors as long as ACP and its affiliates beneficially hold Series B Preferred Stock with an aggregate liquidation preference of $150 million or more, and (ii) one Purchaser Director so long as ACP and its affiliates hold Series B Preferred Stock with an aggregate liquidation preference of $50 million or more. If ACP or the Majority Holders elect not to designate or elect a Purchaser Director, then ACP, acting by the consent of the Majority Holders, may cause one non-voting observer of the Board to be appointed.
Voting Agreement